D-Index & Metrics Best Publications
Research.com 2022 Best Female Scientist Award Badge
Microbiology
Australia
2022

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 87 Citations 36,242 444 World Ranking 202 National Ranking 6
Medicine D-index 99 Citations 49,159 785 World Ranking 4006 National Ranking 127
Best female scientists D-index 99 Citations 49,918 774 World Ranking 919 National Ranking 33

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Female Scientist Award

2022 - Research.com Microbiology in Australia Leader Award

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Cancer
  • Disease

The scientist’s investigation covers issues in Internal medicine, Gynecology, Vaccination, Cervical cancer and Immunology. Her studies deal with areas such as Antibiotics and Vaccine efficacy as well as Internal medicine. Her Gynecology research is multidisciplinary, incorporating perspectives in Chlamydia, Men who have sex with men, Placebo, Obstetrics and Gonorrhea.

Her Vaccination study integrates concerns from other disciplines, such as Young adult, Papillomaviridae, Immunization, Genital warts and Cohort. The study incorporates disciplines such as Gardnerella vaginalis, Disease, Papillomavirus Vaccines and Gardasil in addition to Immunology. Her research integrates issues of Colposcopy and Intraepithelial neoplasia in her study of Cervical intraepithelial neoplasia.

Her most cited work include:

  • Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study (1651 citations)
  • Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. (1570 citations)
  • Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. (1570 citations)

What are the main themes of her work throughout her whole career to date?

Her primary areas of study are Gynecology, Internal medicine, Cervical cancer, Vaccination and Virology. Her Gynecology research integrates issues from Young adult, Papillomaviridae, HPV infection and Obstetrics. Her Internal medicine research includes themes of Men who have sex with men, Oncology and Genotype.

Her Cervical cancer study results in a more complete grasp of Cancer. The subject of her Vaccination research is within the realm of Immunology. Her research in Virology intersects with topics in Polymerase chain reaction and Microbiology.

She most often published in these fields:

  • Gynecology (40.22%)
  • Internal medicine (39.31%)
  • Cervical cancer (28.27%)

What were the highlights of her more recent work (between 2017-2021)?

  • Internal medicine (39.31%)
  • Vaccination (22.90%)
  • Cervical cancer (28.27%)

In recent papers she was focusing on the following fields of study:

Suzanne M. Garland focuses on Internal medicine, Vaccination, Cervical cancer, Mycoplasma genitalium and Papillomaviridae. Suzanne M. Garland has researched Internal medicine in several fields, including Gastroenterology, Chlamydia and Men who have sex with men. Her study on Vaccination is covered under Immunology.

Her study in Cervical cancer is interdisciplinary in nature, drawing from both Public health, Oncology, Family medicine and Cervix. Suzanne M. Garland combines subjects such as Genital warts and Papillomavirus Vaccines with her study of Papillomaviridae. Her Anal cancer research includes themes of Anal canal, Squamous intraepithelial lesion, Anoscopy and Incidence.

Between 2017 and 2021, her most popular works were:

  • Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes : updated systematic review and meta-analysis (275 citations)
  • Outcomes of Resistance-guided Sequential Treatment of Mycoplasma genitalium Infections: A Prospective Evaluation (86 citations)
  • Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination (71 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

Her primary areas of investigation include Internal medicine, Papillomaviridae, Cervical cancer, Vaccination and Incidence. Her research in Internal medicine intersects with topics in Men who have sex with men, Gastroenterology, Placebo, Mycoplasma genitalium and Azithromycin. The Papillomaviridae study combines topics in areas such as Immunohistochemistry, Genotyping, Head and neck cancer and Cervical intraepithelial neoplasia.

Her studies deal with areas such as Genotype, Vaccine efficacy, Family medicine and Cervix as well as Cervical cancer. Her Vaccination research is multidisciplinary, relying on both Human Papilloma Virus Vaccine, Human papillomavirus, Young adult, Genital warts and HPV infection. In her study, Anoscopy is inextricably linked to Anal cancer, which falls within the broad field of Incidence.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Suzanne M. Garland;Suzanne M. Garland;Mauricio Hernandez-Avila;Cosette M. Wheeler;Gonzalo Perez.
The New England Journal of Medicine (2007)

2238 Citations

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

Silvia de Sanjose;Wim G.V. Quint;Laia Alemany;Daan T. Geraets.
Lancet Oncology (2010)

2167 Citations

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

J. Paavonen;P. Naud;J. Salmeron;C. M. Wheeler.
The Lancet (2009)

2128 Citations

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

Elmar A. Joura;Anna R. Giuliano;Ole-Erik Iversen;Celine Bouchard.
The New England Journal of Medicine (2015)

1154 Citations

Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis

Dorothy A Machalek;Mary Poynten;Fengyi Jin;Christopher K Fairley.
Lancet Oncology (2012)

862 Citations

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

Matti Lehtinen;Jorma Paavonen;Cosette M. Wheeler;Unnop Jaisamrarn.
Lancet Oncology (2012)

781 Citations

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

Elmar A Joura;Sepp Leodolter;Mauricio Hernandez-Avila;Cosette M Wheeler.
The Lancet (2007)

747 Citations

A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines

John T. Schiller;Xavier Castellsagué;Suzanne M. Garland.
Vaccine (2012)

726 Citations

High Recurrence Rates of Bacterial Vaginosis over the Course of 12 Months after Oral Metronidazole Therapy and Factors Associated with Recurrence

Catriona S. Bradshaw;Anna N. Morton;Jane Hocking;Suzanne M. Garland.
The Journal of Infectious Diseases (2006)

621 Citations

Comprehensive control of human papillomavirus infections and related diseases.

F. Xavier Bosch;Thomas R. Broker;David Forman;Anna Barbara Moscicki.
Vaccine (2013)

603 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Suzanne M. Garland

Christopher K. Fairley

Christopher K. Fairley

Monash University

Publications: 198

Catriona S. Bradshaw

Catriona S. Bradshaw

Monash University

Publications: 136

Joakim Dillner

Joakim Dillner

Karolinska University Hospital

Publications: 110

Lauri E. Markowitz

Lauri E. Markowitz

National Center for Immunization and Respiratory Diseases

Publications: 107

Joel M. Palefsky

Joel M. Palefsky

University of California, San Francisco

Publications: 94

Mark Schiffman

Mark Schiffman

National Institutes of Health

Publications: 93

Julia M.L. Brotherton

Julia M.L. Brotherton

University of Melbourne

Publications: 91

Wim Quint

Wim Quint

Erasmus University Rotterdam

Publications: 91

Elizabeth R. Unger

Elizabeth R. Unger

Centers for Disease Control and Prevention

Publications: 86

Eduardo L. Franco

Eduardo L. Franco

McGill University

Publications: 84

Silvia de Sanjosé

Silvia de Sanjosé

University of Barcelona

Publications: 80

Anna R. Giuliano

Anna R. Giuliano

University of South Florida

Publications: 80

Matti Lehtinen

Matti Lehtinen

Karolinska Institute

Publications: 76

Chris J.L.M. Meijer

Chris J.L.M. Meijer

Vrije Universiteit Amsterdam

Publications: 74

Luisa L. Villa

Luisa L. Villa

Universidade de São Paulo

Publications: 71

John M. Kaldor

John M. Kaldor

UNSW Sydney

Publications: 70

Trending Scientists

Giacomo Morabito

Giacomo Morabito

University of Catania

Simon E. Fisher

Simon E. Fisher

Max Planck Society

Julian Gough

Julian Gough

MRC Laboratory of Molecular Biology

Scott D. Bridgham

Scott D. Bridgham

University of Oregon

Mitsue Miyao

Mitsue Miyao

Tohoku University

James J. Moon

James J. Moon

University of Michigan–Ann Arbor

Mark Peggie

Mark Peggie

University of Dundee

Catherine J. Pallen

Catherine J. Pallen

University of British Columbia

David J. Patterson

David J. Patterson

University of Sydney

John E. Guest

John E. Guest

University College London

Douglas L. Mann

Douglas L. Mann

Washington University in St. Louis

Tobias Kurth

Tobias Kurth

Charité - University Medicine Berlin

Xianbo Zhao

Xianbo Zhao

Central Queensland University

John Porter

John Porter

University of London

Tarani Chandola

Tarani Chandola

University of Manchester

Daniel Byman

Daniel Byman

Georgetown University

Something went wrong. Please try again later.